Approval · Notice of Compliance 13018 · 2012
4XLA: Notice of Compliance 13018
Issued February 9, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13018
- Date
- February 9, 2012
- Company
- Ecolab Co.St. Paul, Minnesota, United States
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional Claim
- Therapeutic class
- Antiseptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| 4XLA | 02047780 | Marketed |
Medicinal ingredients
- GLYCERINE 10 PER
- LACTIC ACID 2.64 PER
- SODIUM CHLORITE 0.64 PER